1 year 2 mnlhs, man !Xl for heidit was + 3.1 * 0.42 SD, man bone age was I 4 ye-6 Months 1 yecu 3 nonbs, g u k r t a l devrloyxnent was s c a d Tannrr s k g c 111 (rr-1 ) and IV (17-4). k f o r r trt'aknt, physlolog~cal 24 hour Ql secretion, QI respcme to ' IF01 and 0UUi st~niulation tests, SmC levels and others pltultary funuc tions r v r~ rvaluakl. 3% 201-CB5 was given tw~ce daily usin(: 2 subcutancorn Injection of 2 9 ug a t 8. CO MI and 8.02 FM. For the whole m, growth velocity had s m l y d e c~a s r d \% 2.82 only versus 6.9 2 2.35 mly) , p t h was c a i p l c tely b l m k d in 3 potienk. One b y aged 15 years 9 r r c n t l~ baa the same p t i l velmi ty isfore and after trvatrnenl. 117c l a s t patient hail p m v~a s l y h n hmtcd iuu;uccessfiiLly by bbmnrrypt~ne durirg onr yrar md dflrr 3 rrrvlths of S'6 20-'395 t h e q y growth velcxity had decreased ( b / y vrrsus 10 on/y before trvati~n t ) .
Tolerance of tlri:; thmrq~y was good hmever t r m l m t . diarrl~ca and rnusra ihir~ng the f i r s t ten &ys t~~d m c m~ In a l l cascs. R a~t~n r brologlral piu;lluL ters m i n e d norrrwl.
CCNCLliSICN : Yhese preliln~iwy results sipgest thi cfficacy of 35 20l-SB5 I n & u c i l~ p 1 f f 1 velmity In children with c o n s t~b~t l unal tall slature ui~thout mmjor side effects. Among 40 c h i l d r e n w i t h r e c e n t t y p e 1 IDDN t r e a t e d w i t h c y c l os p o r i n A (CyA), 7 i n t e r r u p t e d i n s u l i n i n j e c t i o n s 48 t 5 days a f t e r t h e o n s e t of t h e r a p y and t h e r e a f t e r m a i n t a i n e d t h e i r HbAlC l e v e l below 7.5% [ N : 4 . 8 i 0 . 7 ( s d ) % ] . We compared t h i s group w i t h t h e 13 p a t i e n t s who could n o t m a i n t a i n sucli g l u c o s e c o n t r o l w i t h o u t i n s u l i n . No d i f f e r e n c e s were d e t e c t e d i n terms of age (10.2 v s 9.8 y r s ) , and 12 h r t r o u g h l e v e l s (RIA) i n blood were s i m i l a r (273 ng/ml v s 299 ng/ml) i n b o t h groups. These d a t a i n d i c a t e t h a t t h e e a r l y r e s p o n s e t o CyA depends p r im a r i l y on t h e p r e c o c i t y o f i m n~u n o i n t c r v e n t i o n and t h e p e r s i s t e n c e o f s u f f i c i e n t b e t a c e l l f u n c t i o n . S e l e c t i o n o f p a t i e n t s based on t h e s e p a r a m e t e r s should f u r t h e r i n c r e a s e t h e f r e q u c n c y of ( : a~-l y r e m i s s i o n s i n f u t u r e t r i a l s of immunosuppression i n r e c e n t IDDM.
C o u n t e r r e g u l a t o r y r e s p o n s e s t o i n s u l i n -i n d u c e d Iiypoglyceo~ia were nreasured i n 6 d i a b e t i c s wit11 f r c q u c n t s e v e r e hypoglycemic e p i s o d e s (group 1 ) and i n 6 w i t h o u t s e v e r e l~ypoglycemia (group 2 ) . Group 1 d i d n o t d i f f e r from group 2 r e g a r d i n g a g e (17.8kSD2.5yr v s 18.421.6), d u r a t i o n of d i a b e t e s (12.7'2.2yr v s 1 0 . 0 + 3 . 4 ) , llbAl (9.721.02 v s 1 0 . 9 ? 1 . 9 ) , S . C . i n s u l i n t h e r a p y and g l u c o s e l e v e l s on t h e morning of t h e t e s t (4.9t1.3mM v s 6.211.1). The i n s u l i n i nf u s i o n was t l i e~l a d j u s t e d t o lower plasma g l u c o s e t o 2.5k0.4mCI and 2 . 5 t 0 . 7 w i t h i n 2h. R a t e of g l u c o s e d i s a p p e a r a n c e , c a l c u l a t e d irom plasma i s o t o p i c enrichment o f s t a b l e d i d c u t e r o g l u c o s e , i n c r e a s e d t o 4.4tl.Omg/kg/min and 4 . 0 t 1 . 1 , r a t e of nppearancc dropped t o 2.2+0.5mg/kg/min and 1 . 7 t 0 . 4 . llormonal r e s p o n s e s t o I~ypoglycemia ( a r e a under c u r v e of g l ucagon, e p i n e p h r i n e , growth l~ormonc rind c o r t i s o l ) were n o t d i f f c r e~l t I~etween tlie g r o u p s . Marked d e c r e a s e s o c c u r r e d i n f r e e f a t t y a c i d s , 3-011-butyrate and branched-chain amino a c i d s . A l a n i n e d i d n o t change. S i x p a t i e n t s were f o u n d , 1 i n e a c h group, who had e i t h e r no glucagon r e s p o n s e t o hypoglycemia ( b e 1 . o~ 130pg/mL), o r a v e r y low e p i n c p l~r i n c r c s p o~~s e (below 3 . 0 nmol/L), o r I~o t l i con~bincd. I n c o n c l u s i o n , d e s p i t e s e v e r e I~y i~o z l y c -
emic e p i s o d e s , hormonal c o u n t e r r e g u l u t i o n may be uninrpaired i n some p a t i e n t s . On t l~e o t h e r hand, long-term absence of liypoglycemic a t t a c k s does n o t g u a r a n t e e i n t a c t g l u c o s e c o u n t e r r e g u l a t i o n . 
t o b a s a l p l a s m g l u c o s e (FG) was g i v e n b e f o r e 'and :gain a f t e r 3 d a y s o f i n t e n s i v e i n s u l i n t h e r a p y ( I I T ) . O r a l questionn a i r e s r c g a r d i n g hypoglycemic (11) symptoms werc colnpleted a t e a c h time blood. m p l c s w e r c tc&en f o r m a s u r e m e n t s of I G and CATS. An hypoglycemic awareness score (HAS) was a s s i g n e d t o e a c h pat i e n t . A l l b u t l p a t i c n t r e p o r t e d sympttoms d u r i n g e a c h test.
These o c c u r r e d p r i o r t o A ( K > 6 5 mg", i n 73",fore r e d 52% a E t c r I I T . The i n i t i a l syrrptoms ( u s u a l l y h u n g e r ) apppcared a t 38+26 min b e f o r e a n d 35+18 n u n a f t e r I I T a f t e r FG d e c r e m e n t s o f 121k81 ( 4 7 t 2 8 3 and 88t64 rrg",(46f26%) r e s p . (NS). The CAT i n c r e m e n t s a t t h i s t i m were v c r y ~m l l (174k55, r a n g e 0-802 a n d 70k89, 0-262 m/ml r e s p . ) . The m~x I A S c o r r e l a t f d n q a t i v e l y w i t h PG n a d i r , b e f o r e (I=-.69, p < .001) b u t n o t a f t e r I I T . The max H A S c o r r e l a t e d w i t h p e a k CAT r e s p o n s e b c f o r e ( r = . 4 2 , p < .05) and a f t e r (r=0.42, p < .05) I I T . I n p a t i c n t s w i t h M; rkidir < 65 ~iq:, therc were n o d i f f e r e n c e s i n IlAS o r g l u c o s e r e c o v e r y b e f o r e a n d a f t e r I I T d e s p i t e t h e f a c t t h a t CAT r e s p o n s e was s i g n i f i c a i t l y lower a f t e r I I T w i t h s o m p a t i c n t s n e v e r a c h i e v i n g a n i n c r e m e n t > 2 5 0 m/ml. Thus, 11 unawareness i s n o t comnon,in c h i l d r e n wi.th IDD & symptoms o c c u r p r l o r t o o n s e t of I1 w l t h mlnlmal l f a n y CAT i n c r m n t s . 
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and Splnderborg I-iospital, Denmark.
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FLUID ADMINISTRATION R A T E AFFECTS ONSET OF B R A I N -RFSIDUAL I3 CELL FUNCTION IN TRANSIENT NEO-STEM HERNIATION (BH) I N DIABETIC KETOACIDOSIS (DKA) NATAL DIABETES MELLITUS (TNDM)
C e r e b r a l edema p r o b a b l y o c c u r s u n i v e r s a l l y w i t h i n s u l i n and f l u i d t r e a t m e n t o f s e v e r e DKA. The In TNDM a delayed maturation of insulin secretion has been suggestc a u s e o f l i f e -t h r e a t e n i n g BH d u r i n g t r e a t m e n t o f D K A i s unknown.
ed. Ijowever, concentrations of C-peptide ( C -P~P ) -a reliable measure No recommendations a r e p r o f f e r e d i n r e c e n t r e v i e w s t o s u g g e s t of pancreatic R cell function -and of proinsulin in plasma (P) have ways t o p r e v e n t BH. H i s t o r y , l a b o r a t o r y d a t a , r a t e o f f l u i d not been reported. In 4 babies (birth weight 1800-1954 g, g e s t a t~o n a l a d m i n i s t r a t i o n and r a p i d i t y o f o n s e t from n i n e new c a s e s o f BH a g e 32-37 weeks) with TNDM from day 5-11 of life, P-proinsulin, P-inp l u s 33 c a s e s from t h e l i t e r a t u r e were a n a l y z e d . Of n o t e , c a lsulin IgG antibody (P-IAb) a s well a s serial measurements o f P-glucose c u l a t e d sodium cone. (M. K a t z , NEJM (1973) 289:843) d e c r e a s e d and P-C-pep were carried out. In 3 patients without IAb on admission, between i n i t i a t i o n o f t h e r a p y and t h e h o u r o f o n s e t o f BH P-glucose was 38.7-64 mmol/l, P-proinsulin <1.2-2.2 pmol/l (ref.: 1.2-(138.7 2 6.2 mM v s 134.1 + 8 . 3 mM, t z 2 . 6 8 , p = . 0 2 ) , and t h e s e 13 pmolll). P-C-pep values were <0. 06 and 0.06 nmol/l (ref.: 0.18- were c o r r e l a t e d : r z 0 . 6 1 , p<0.01, n=18. Serum K+ conc. d e c r e a s e d 0.63 nmolll), respectively, in patients I and I1 who had an insulin d u r i n g t h e same time p e r i o d (5.0 + 0 . 9 v s 3.7 + 1.0 mM; t.5.54, requirement of 4 i.u. per kg and 24h. In patient 111, P-C-pep was p<0.001) b u t were n o t c o r r e l a t e d . These d a t a w i t h t h e 0.15 nmol/l initially and t h e insulin dose 2 i.u. per kg and 24h.
knowledge t h a t v a s o p r e s s i n i s i n a p p r o p r i a t e l y r e g u l a t e d i n DKA, P a t i c n t IV had an initial P-glucose of 16 mmolll, a P-C-pep of 0.33 s h o u l d a l e r t t h e p h y s i c i a n t o be aware o f t h e syndrome o f nmolll, a P-IAb o f 3.09 mU/ml, and a moderate insulin requirement ( I i n a p p r o p r i a t e ADH i n e x a c e r b a t i n g BH. Unpaired t -t e s t a n a l y s i s i.u. per kg and 24h). In patients I, 11, and 111, t h e P-C-pep rose to e x c l u d e d f a c t o r s o f s e x , p r e v i o u s d i a g n o s i s o f d i a b e t e s , NaHC03 reference levels concomitantly with a decrease in insulin requirement i n t h e i n i t i a l f l u i d t r e a t m e n t o r t h e p r e s e n c e of s t u p o r on (withdrawal of insulin a f t e r 86, 88, and 15 days, resp.). In patient a d m i s s i o n a s a f f e c t i n g l a b o r a t o r y v a l u e s , f l u i d a d m i n i s t r a t i o n IV, P-C-pep remained a t r e f e r e n c e concentrations, the insulin requirer a t e s o r o n s e t o f BH. Only t h e r a t e of f l u i d a d m i n i s t r a t i o n ment decreasing with a concurrent decrease in P-IAb (withdrawal of ( 7 . 4 + 2.8 L/m2/day; nz4O) was s i g n i f i c a n t l y r e l a t e d t o therapy a f t e r 68 days). Conclusion: P-C-pep and P-IAb -but not the r a p i d i t y o f o n s e t o f BH ( r = -0 . 3 2 , p z . 0 4 ) .
Only 4 o f 40 c a s e s initial P-glucose or birthweight -a r e of prognostic significance in o c c u r r e d when f l u i d a d m i n i s t r a t i o n was <4 L/m2/day. t h e t r e a t m e n t of TNDM.
Plitation o f t h e r a t e o f f l u i d a d m i n i s t r a t i o n t o a v a l u e <4 L/m /day cont i n u e s t o be a p r u d e n t recommendation i n t h e t r e a t m e n t o f DKA.
